Immediate Impact

26 standout
Sub-graph 1 of 13

Citing Papers

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
VEGF signaling: Role in angiogenesis and beyond
2024 Standout
2 intermediate papers

Works of Pierre Van Mol being referenced

Immunotherapy in unresectable stage III non-small-cell lung cancer: state of the art and novel therapeutic approaches
2022
Capmatinib for the treatment of non-small cell lung cancer
2019

Author Peers

Author Last Decade Papers Cites
Pierre Van Mol 95 88 7 56 10 218
Nia Adeniji 69 27 49 69 10 252
Katie Wood 144 102 32 32 12 292
Lorenzo Ruggieri 233 92 21 71 13 293
Simone Navarra 138 31 19 132 13 253
Yang Dongliang 24 43 24 71 11 153
S Mills 85 49 30 60 7 263
Chensheng W. Zhou 171 91 93 82 11 257
Chin‐Hee Chung 176 161 61 62 15 294
Marco Polo Peralta Álvarez 118 85 21 37 11 190
Yingjie Wu 39 28 17 57 13 204

All Works

Loading papers...

Rankless by CCL
2026